While subcutaneous injection into the lower limbs may be possible, it is generally not recommended as a preferred injection site due to the possible complications involved including tissue damage and injection site reactions: The skin in the lower limbs is typically thinner and more sensitive than other parts of the body, which can increase the risk of pain, bleeding, and infection
Furthermore, both compounds have generated significant scientific interest for their roles in tissue-related and cellular signalling pathway research
What Realistic Results Look Like Most patients on a clinically appropriate BPC-157 protocol report a recognizable pattern: weeks 12 , subtle inflammation reduction
[6:08 PM]source: BPC-157 Oral vs Injection: Benefits, Risks, and Efficacy When comparing the two routes, consider onset of action, safety, convenience, and cost